Source: Annual Congress 2006 - Update on treatment of COPD II
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
O. Lorenzo, J. Abreu, C. Hernández, P. Abreu, N. Lorenzo (La Laguna, Spain). Uric acid, oxidative stress and inhaled steroids in stable chronic obstructive pulmonary disease. Eur Respir J 2006; 28: Suppl. 50, 2502

Member's Comments

No comment yet.

Related content which might interest you: Oxidative stress and inhaled steroids in stable chronic obstructive pulmonary disease Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD Year: 2008 Oxidative stress and inhaled steroids in stable chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 295s Year: 2005 Oxidant metabolism in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: 14S-27S Year: 2003 Bronchodilator therapies reduce oxidant stress and LTB4 activation in chronic obstructive pulmonary disease subjects Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II Year: 2008 Role of inhaled antioxidants in chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 717s Year: 2005 Oxidative stress and chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=100 Year: 2006 Rosuvastatin effects on systemic inflammation, oxidative stress and antioxidants in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – COPD diagnosis and management Year: 2016 Implications for disease and therapy Source: Annual Congress 2005 - Oxidative and nitrative stress: control of cell function in COPD Year: 2005 Antioxidant properties of N-acetylcysteine: their relevance in relation to chronic obstructive pulmonary disease Source: Eur Respir J 2004; 23: 629-636 Year: 2004 Evaluation of oxidative stress on pathogenesis and severity of chronic obstructive pulmonary disease Source: Annual Congress 2008 - Structural remodelling in COPD Year: 2008 Cachexia in patients with acute COPD exacerbations: relationship to pulmonary function, systemic inflammation and oxidative stress Source: Annual Congress 2008 - Comorbidities in COPD Year: 2008 Influence of systemic inflammation and hypoxaemia on bone metabolism in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Corticosteroid sensitivity in patients with chronic obstructive pulmonary disease is restored by theophylline Source: Annual Congress 2005 - Therapeutic options for COPD: present and future Year: 2005 Uric acid and bronchial oxidative stress in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 634s Year: 2006 Association of oxidative stress and inflammation with cardiovascular injury in chronic obstructive pulmonary disease Source: Annual Congress 2009 - Mechanisms of pulmonary inflammation and fibrosis Year: 2009 8-isoprostane as a marker of oxidant stress in non-symptomatic cigarette smokers and COPD Source: Annual Congress 2006 - New investigational approaches to smoking and smoking cessation Year: 2006 The role of inflammation in COPD Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases Year: 2006 Markers of apoptosis and nitrosative stress in chronic obstructive pulmonary disease Source: Annual Congress 2010 - Novel mechanisms in COPD Year: 2010 Systemic inflammation and systemic oxidative stress in patients with acute exacerbations of COPD Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 Serum lysophosphatidic acid levels and exacerbation frequency in chronic obstructive pulmonary disease (COPD) Source: Virtual Congress 2020 – Ageing, metabolic syndrome and the lung Year: 2020